Arkolith/Insider Trading/RPTX/Form 4

Zinda Michael

EVP, Chief Scientific OfficerRepare Therapeutics Inc. (RPTX) · full profile →Form 4 · filed Jun 9, 2023
Net Selling
Open-Market Buys
$34K
Open-Market Sells
$77K
Net Open-Market Flow
-$43K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2023Buy(S)3K$12.02$34K60K
Jun 7, 2023Sell(S)6K$12.03$77K63K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-035858) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML